23 February 2021
The NHS Commercial Framework for New Medicines has been published.
19 February 2021
The European Commission has issued a positive preliminary data adequacy decision for the UK which will allow data to continue to flow freely from the EU to the UK.
15 February 2021
The government has published new data on the life science sector in the UK and other countries.
15 February 2021
The Chancellor is being urged by a coalition of top industry leaders to kickstart the recovery and levelling up by allowing capital expenditure to qualify for R&D tax credits.
17 February 2021
Thalassaemia major is a serious, genetic blood disorder. Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.
17 February 2021
Nicola Redfern, General Manager of bluebird bio in the UK, describes the commercial challenges for rare disease medicines in the UK and reflects on the opportunities of gene therapies.